Focal One System Enhances Precision Tissue Ablation, Reduces Side Effects for Prostate Cancer Patients LYON, France -- January 3, 2019 - EDAP TMS SA (Nasdaq: EDAP) today announced that the John Wayne Cancer Institute (JWCI) at the Providence Saint John's Health Center in Santa Monica, CA is the

Warrants for 1.5 Million Ordinary Shares in the Form of American Depository Shares Expired on November 29, 2018 Capital Structure Now Comprised Exclusively of Common Stock LYON, France , November 29, 2018 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global leader in therapeutic ultrasound,

LYON , France, November 20, 2018  -  EDAP TMS SA  (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will provide a corporate overview at the Piper Jaffray Conference , taking place November 27-29, 2018 in New York City .

Generated revenue growth of more than 14% as compared to the third quarter of 2017 Continued geographic expansion of Focal One with installations in Brazil and South Korea Since receiving FDA clearance for Focal One in June 2018 , progressed through the lengthy capital equipment sales cycle with

LYON, France , November 6, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the third quarter and nine months ended September 30, 2018 , after the close of the financial markets on Wednesday, November 14,

MONTREAL, QUEBEC - OCTOBER 24, 2018 - Urologists, uro-oncologists and urology department chairs from renowned American universities will spend a day - October 25, 2018 -- at Jewish General Hospital , a McGill University teaching hospital, where they will learn to perform a more precise outpatient

   Warrants for Approximately 3.3 Million Ordinary Shares in the Form of American Depository Shares Expired on October 14, 2018 LYON, France , October 15, 2018 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global leader in therapeutic ultrasound, announced today that warrants for approximately

HIFU Prostate Cancer Treatments Successfully Performed at Albert Einstein Hospital , Sao Paulo LYON, France , September 27, 2018 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the installation of the third Focal One device in Brazil at the renowned Albert

AUSTIN, TX - LYON, France , September 26, 2018 - EDAP TMS (Nasdaq: EDAP) today announced the results of a study conducted at Houston Methodist Medical Center in Houston, TX that showed High Intensity Focused Ultrasound (HIFU) to be safe and effective, with oncologic control for prostate cancer

Successful HIFU Treatments Performed in Seoul National University Bundang Hospital LYON, France , September 20, 2018 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the installation of the first Focal One device in South Korea , at the renowned Seoul